| Hans-Günter Meyer-Thompson | Buprenorphin
Long -Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder.
Long -Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder.
Maremmani I, Dematteis M, Gorzelanczyk EJ, Mugelli A, Walcher S, Torrens M.
J Clin Med. 2023 Aug 26;12(17):5575. doi: 10.3390/jcm12175575. PMID: 37685642; PMCID: PMC10488107.